Cart
sales@molnova.com
Cassiaside
CAS No. 123914-49-8
Cassiaside ( )
Catalog No. M31454 CAS No. 123914-49-8
Cassiaside has significant hepato-protective effects against galactosamine damage, which is higher than that of silybin from Silybum marianum. Cassiaside demonstrates significant antimutagenic, and 1,1-diphenyl-2-picrylhydrazyl(DPPH) radical scavenging effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 313 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameCassiaside
-
NoteResearch use only, not for human use.
-
Brief DescriptionCassiaside has significant hepato-protective effects against galactosamine damage, which is higher than that of silybin from Silybum marianum. Cassiaside demonstrates significant antimutagenic, and 1,1-diphenyl-2-picrylhydrazyl(DPPH) radical scavenging effects.
-
DescriptionCassiaside has significant hepato-protective effects against galactosamine damage, which is higher than that of silybin from Silybum marianum. Cassiaside demonstrates significant antimutagenic, and 1,1-diphenyl-2-picrylhydrazyl(DPPH) radical scavenging effects. Cassiaside and emodi show mixed-type inhibition against β-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1).
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
RecptorAChR | BChE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123914-49-8
-
Formula Weight404.4
-
Molecular FormulaC20H20O9
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Planta Med. 1997 Feb;63(1):11-4.
molnova catalog
related products
-
Emodin-8-O-beta-gent...
Emodin-8-O-beta-gentiobioside is a natural product for research related to life sciences.
-
Axillarin
Axillarin has antioxidant activity, it shows xanthine oxidase inhibitory activity ( IC(50) :36.0 uM).
-
CH5132799
CH5132799 has been used in trials studying the treatment of Solid Tumors.
